Alphabiome
PrivateLast Round
Seed
May 6, 2025
Total Funding Raised
$8M
Company Overview
Alphabiome operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in May 2025.
Alphabiome is a biotechnology company that develops an AI-powered platform to analyze microbial genetic data for precision medicine and drug efficacy prediction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphabiome Comparables
Compare Alphabiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xbiome | 76% | |
| Persephone Biosciences | 69% | |
| Ardigen | 61% |
For institutional investors. Book with your work email.
Alphabiome Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Alphabiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AIX Ventures | Seed |
| New Era Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 216% MoM, reaching 982.
- Aug 25, 2025
Grew 125% QoQ from 4 to 9 employees.
For institutional investors. Book with your work email.
Alphabiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alphabiome's valuation, stock price, and market status.
Is Alphabiome a public or private company?
Alphabiome is a private company.
What is the current stock price of Alphabiome?
Alphabiome is a private company, so its shares have no public market price. Caplight tracks Alphabiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alphabiome worth (valuation)?
Valuation information for Alphabiome is not publicly available.
Can I buy Alphabiome stock?
Alphabiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alphabiome's last funding round?
Alphabiome's most recent funding round was Seed on May 6, 2025.
Who are the main investors in Alphabiome?
Key investors in Alphabiome include AIX Ventures, New Era Capital Partners.
Will Alphabiome IPO soon?
No public IPO plans have been announced for Alphabiome.
How can I track Alphabiome secondary market activity?
Caplight tracks bids, offers, and trades in Alphabiome's shares on secondary markets.